Nachrichten zur Oramed Pharmaceuticals Aktie

ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness

By M. MarinNASDAQ: ORMPREAD THE FULL ORMP RESEARCH REPORTGains on investment portfolio + service agreement income contributed to 2Q26 EPS…

ORMP: View Inclusion in Russell Indexes as Positive That Could Raise Awareness in Investment Community

By M. MarinNASDAQ: ORMPREAD THE FULL ORMP RESEARCH REPORTORMP shares to be added to the Russell 2000® & Russell 3000®As…

ORMP: Strategically Acquiring Interests in Medtech & Technology Companies

By M. MarinNASDAQ: ORMPREAD THE FULL ORMP RESEARCH REPORTStrategically acquiring controlling interests in portfolio of companiesOramed Pharmaceuticals (NASDAQ: ORMP) is…

Oramed Pharmaceuticals: Hold On Oral Insulin Drug Failure Pivot And New Strategic Investment Direction

…

ORMP: Enabling Participation in Both ORMP & LFWD Businesses Expected to Enhance Shareholder Value

By M. MarinNASDAQ:ORMPREAD THE FULL ORMP RESEARCH REPORTTransaction enables exposure to both oral drug delivery program & medical device businessesOramed…

Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback

…

ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted

By M. MarinNASDAQ:ORMPREAD THE FULL ORMP RESEARCH REPORTADVANCING ORMD-0801 THROUGH CLINICAL STUDIESTrial will focus on key patient subpopulations that have…

Scilex Holding Company Announces Extension of the Maturity Date of its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an…

Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies

PALO ALTO, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”),…

dpa-AFX ProFeed